1 – 33 of 33
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
(
- Contribution to journal › Article
- 2020
-
Mark
Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma
(
- Contribution to journal › Article
- 2019
-
Mark
Molecular subtypes applied to a population-based modern cystectomy series do not predict cancer-specific survival
(
- Contribution to journal › Article
- 2018
-
Mark
Low Frequency of Intratumor Heterogeneity in Bladder Cancer Tissue Microarrays
(
- Contribution to journal › Article
- 2017
-
Mark
HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts
(
- Contribution to journal › Article
- 2015
-
Mark
Reply from Authors re: Bas W.G. van Rhijn, Mark A. Behrendt, Kees Hendricksen, Theo H. van der Kwast. Toward Optimal Prediction of Prognosis in T1 Urothelial Carcinoma of the Bladder. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.03.030.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.
(
- Contribution to journal › Article
- 2014
-
Mark
Infiltration of CD3(+) and CD68(+) cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
(
- Contribution to journal › Article
- 2013
-
Mark
Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
(
- Contribution to journal › Article
-
Mark
Toward a Molecular Pathologic Classification of Urothelial Carcinoma.
(
- Contribution to journal › Article
-
Mark
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.
(
- Contribution to journal › Article
- 2012
-
Mark
Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma.
(
- Contribution to journal › Article
-
Mark
The Importance of Being Grade 3: WHO 1999 Versus WHO 2004 Pathologic Grading.
(
- Contribution to journal › Article
-
Mark
A Molecular Taxonomy for Urothelial Carcinoma.
(
- Contribution to journal › Article
-
Mark
DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status.
(
- Contribution to journal › Article
- 2011
-
Mark
The value of bladder mapping and prostatic urethra biopsies for detection of carcinoma in situ (CIS).
2011) In BJU International(
- Contribution to journal › Article
-
Mark
A Systematic Study of Gene Mutations in Urothelial Carcinoma; Inactivating Mutations in TSC2 and PIK3R1.
(
- Contribution to journal › Article
-
Mark
Can tissue microarray-based analysis of protein expression predict recurrence of stage Ta bladder cancer?
(
- Contribution to journal › Article
- 2010
-
Mark
Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome.
(
- Contribution to journal › Article
- 2009
-
Mark
MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31.
(
- Contribution to journal › Article
- 2008
-
Mark
Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors.
(
- Contribution to journal › Article
-
Mark
Recurrent and multiple bladder tumors show conserved expression profiles.
(
- Contribution to journal › Article
- 2007
-
Mark
Urothelial carcinoma in the prostatic urethra and prostate: current controversies
(
- Contribution to journal › Scientific review
-
Mark
Prospective study of transitional cell carcinoma in the prostatic urethra, and prostate in cystoprostatectomy specimen
(
- Contribution to journal › Article
-
Mark
Distinct mitotic segregation errors mediate chromosomal instability in aggressive urothelial cancers.
(
- Contribution to journal › Article
- 2006
-
Mark
Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer.
(
- Contribution to journal › Article
- 2005
-
Mark
HER2-testning för bröstcancer. Kvalitetssäkrad analys av tillväxtfaktor erbjuds nu på svenska laboratorier
(
- Contribution to journal › Article
-
Mark
Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up.
(
- Contribution to journal › Article
- 2004
-
Mark
Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles.
(
- Contribution to journal › Article
- 2003
-
Mark
Estrogen and progesterone receptor assay in paraffin-embedded breast cancer--reproducibility of assessment.
(
- Contribution to journal › Article
-
Mark
The nested variant of urothelial carcinoma: a rare but important bladder neoplasm with aggressive behavior Three case reports and a review of the literature.
(
- Contribution to journal › Scientific review
-
Mark
Molecular classification of familial non-BRCA1/BRCA2 breast cancer
(
- Contribution to journal › Article
- 2002
-
Mark
Small bowel obstruction caused by intestinal metastases from undiagnosed breast cancer: report of two cases
(
- Contribution to journal › Article